Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 1
1981 1
1984 1
1985 1
1986 1
1987 2
1988 3
1989 5
1990 6
1991 5
1992 9
1993 6
1994 7
1995 10
1996 3
1997 5
1998 4
1999 4
2000 6
2001 2
2002 1
2003 3
2004 4
2005 2
2006 2
2007 2
2008 1
2009 4
2010 4
2011 2
2012 3
2013 5
2014 1
2015 4
2016 6
2017 5
2018 5
2019 4
2020 3
2021 3
2022 2
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Results by year

Filters applied: . Clear all
Page 1
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Zhang Q, Riley-Gillis B, Han L, Jia Y, Lodi A, Zhang H, Ganesan S, Pan R, Konoplev SN, Sweeney SR, Ryan JA, Jitkova Y, Dunner K Jr, Grosskurth SE, Vijay P, Ghosh S, Lu C, Ma W, Kurtz S, Ruvolo VR, Ma H, Weng CC, Ramage CL, Baran N, Shi C, Cai T, Davis RE, Battula VL, Mi Y, Wang J, DiNardo CD, Andreeff M, Tyner JW, Schimmer A, Letai A, Padua RA, Bueso-Ramos CE, Tiziani S, Leverson J, Popovic R, Konopleva M. Zhang Q, et al. Among authors: padua ra. Signal Transduct Target Ther. 2022 Feb 21;7(1):51. doi: 10.1038/s41392-021-00870-3. Signal Transduct Target Ther. 2022. PMID: 35185150 Free PMC article.
p53 activation during ribosome biogenesis regulates normal erythroid differentiation.
Le Goff S, Boussaid I, Floquet C, Raimbault A, Hatin I, Andrieu-Soler C, Salma M, Leduc M, Gautier EF, Guyot B, d'Allard D, Montel-Lehry N, Ducamp S, Houvert A, Guillonneau F, Giraudier S, Cramer-Bordé E, Morlé F, Diaz JJ, Hermine O, Taylor N, Kinet S, Verdier F, Padua RA, Mohandas N, Gleizes PE, Soler E, Mayeux P, Fontenay M. Le Goff S, et al. Among authors: padua ra. Blood. 2021 Jan 7;137(1):89-102. doi: 10.1182/blood.2019003439. Blood. 2021. PMID: 32818241 Free article.
Cellular and gene therapy.
Padua RA. Padua RA. Hemasphere. 2019 Jun 30;3(Suppl):27. doi: 10.1097/HS9.0000000000000265. eCollection 2019 Jun. Hemasphere. 2019. PMID: 35309795 Free PMC article. No abstract available.
From primordial clocks to circadian oscillators.
Pitsawong W, Pádua RAP, Grant T, Hoemberger M, Otten R, Bradshaw N, Grigorieff N, Kern D. Pitsawong W, et al. Among authors: padua rap. Nature. 2023 Apr;616(7955):183-189. doi: 10.1038/s41586-023-05836-9. Epub 2023 Mar 22. Nature. 2023. PMID: 36949197 Free PMC article.
Targeted therapies in myeloid leukemia.
John AM, Thomas NS, Mufti GJ, Padua RA. John AM, et al. Among authors: padua ra. Semin Cancer Biol. 2004 Feb;14(1):41-62. doi: 10.1016/j.semcancer.2003.11.006. Semin Cancer Biol. 2004. PMID: 14757535 Review.
Isotopic biomarker discovery and application in translational medicine.
Bayele HK, Chiti A, Colina R, Fernandes O, Khan B, Krishnamoorthy R, Ozdağ H, Padua RA. Bayele HK, et al. Among authors: padua ra. Drug Discov Today. 2010 Feb;15(3-4):127-36. doi: 10.1016/j.drudis.2009.12.005. Epub 2009 Dec 28. Drug Discov Today. 2010. PMID: 20038454 Review.
Non-dysplastic myelodysplasia?
Cachia PG, Taylor C, Thompson PW, Tennant GB, Masters G, Pettersson T, Whittaker JA, Burnett AK, Jacobs A, Padua RA. Cachia PG, et al. Among authors: padua ra. Leukemia. 1994 Apr;8(4):677-81. Leukemia. 1994. PMID: 8152265
142 results